5.37k followers • 10 symbols Watchlist by The Motley Fool
Companies that not only tend to beat the market, but pay you as they do.
Johnson & Johnson
The Coca-Cola Company
Exxon Mobil Corporation
The Sherwin-Williams Company
Emerson Electric Co.
McCormick & Company, Incorporated
In the latest trading session, Johnson & Johnson (JNJ) closed at $142.85, marking a -0.09% move from the previous day.
In the latest trading session, Coca-Cola (KO) closed at $45.21, marking a -0.04% move from the previous day.
McCormick (MKC) possesses solid growth attributes, which could help it handily outperform the market.
Emergent BioSolutions (EBS) extends a five-year deal with J&J to provide its CDMO services to produce the drug substance of the latter's COVID-19 vaccine candidate. Shares rise.
Investor sentiment for ExxonMobil (XOM) is likely to remain poor until the company comes out with promising results from the massive long-term capital expenditure program.
Act II Global Acquisition to Purchase Two Companies Creating Whole Earth Brands Newly Revised Terms Reflect Just 6.75x 2020 Ebitda vs. 7.9x on Previous Terms New Redemption Deadline is Monday, June 22 and Vote is Wednesday, June 24 New Anticipated Net Leverage is 0.8x vs 1.4x on Previous Terms Company’s Product Sales Already Recovering from […]
Royal Dutch Shell (RDS.A) and ExxonMobil (XOM) issued updates on their upcoming Q2 earnings, while BP plc (BP) agreed to sell its global petrochemicals business for $5 billion.
It was a terrible six months for energy companies, and these giants weren't spared the pain. Here's why things got so bad.
Facebook won't overcome the yawning advertiser revolt in response to hate content overnight, suggests a Goldman Sachs strategist that specializes in tech investing.
The outlook for the nation's restaurants in the wake of COVID-19 isn't pretty, says one celebrity chef.
McCormick (MKC) is witnessing higher demand in the Consumer segment amid the coronavirus outbreak. Also, the company's costs-saving efforts are yielding.
Cintas Corporation (NASDAQ:CTAS) today announced that it will close its Menomonee Falls facility. Cintas regularly examines its operations to determine the optimal structure for continued customer service and future growth, and as such has recently analyzed the Milwaukee market. Based upon this study, and unforeseeable business circumstances related to the COVID-19 pandemic, the company has made the decision to close its Menomonee Falls location at N51 W139915, Northpark Drive as of August 31, 2020 and transition servicing its customers and processing products to other local operations.
What happened Coca-Cola (NYSE: KO) stock is trailing the market this year. Shares have fallen 19% compared to a 4% decline in the S&P 500 through the end of June, according to data provided by S&P Global Market Intelligence.
AWS was already the largest cloud infrastructure platform in the world, and Amazon revealed it was highly profitable -- which could offset the lower margins of its core marketplace business. Locking customers into its Prime ecosystem -- which offered discounts, free shipping, streaming media, and other perks -- further widened its moat against its brick-and-mortar rivals.
Under the deal, starting next year Emergent will provide large-scale manufacturing services to produce the drug substance over five years, with the first two years valued at about $480 million. The news follows a $135 million deal struck by the two companies in April, to use Emergent's manufacturing facilities to speed up the development and production of its vaccine candidate.
The stock market has seen extreme volatility so far in 2020, and even after a strong second-quarter performance, the Dow Jones Industrials (DJINDICES: ^DJI) are still down almost 10% for the year. Although there've been a few stocks that have managed to buck the trend and gained ground, the vast majority of Dow stocks have given up ground. As with all falling stocks, the big question investors have is whether these three giants of their respective industries can bounce back and recover some of their lost ground.
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]
We have publicly tracked our portfolio since 2015, which has beaten the S&P; 500 in terms of total return over this period of time. Most importantly, dividend income continues to grow Continue reading...
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of March 31st, a week after the market trough. Now, we are […]
Jefferies analyst Andy Barish takes a look at recent foot-traffic data, which shows a deceleration in recent weeks for both fast-casual and fast-food restaurants.
Next Generation ICM Offers Remote Programming with Improved Longevity and Enhanced Accuracy DUBLIN, July 07, 2020 -- Medtronic plc (NYSE:MDT), the global leader in medical.
Medtronic plc (MDT), the global leader in medical technology, today introduced the MiniMed™ Mio™ Advance infusion set to all Medtronic insulin pump customers in the United States. The MiniMed Mio Advance infusion set is the newest addition to the MiniMed™ portfolio of infusion sets and gives people using insulin pumps an optimal user experience with fewer steps1. The MiniMed Mio Advance infusion set is inserted in only four steps — individuals simply peel, pinch, place, and press to insert the infusion set.
The U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021. The award is the biggest yet from "Operation Warp Speed", the White House program aimed at accelerating access to vaccines and treatments to fight the coronavirus that causes COVID-19. "What this Warp Speed award does is it pays for production of 100 million doses, which would be delivered starting in the fourth quarter of this year, and may be completed by January or February of next year," Novavax Chief Executive Stanley Erck told Reuters.
Big and mid-cap firms globally are expected to slash capital spending by an average 12% this year as they reel from the fallout of lockdowns and other measures imposed to rein in the coronavirus pandemic, analysts' estimates show. The predicted cut is bigger than the 11.3% decline that occurred in 2009 in the wake of the global financial crisis and would be the steepest drop in the 14 years for which data compiled by Refinitiv is available. Reuters calculated average spending cuts by looking at estimates compiled by Refinitiv for nearly 4,000 firms.